Fairness of legacy admissions questioned; Struggles for Better.com; Spanish Football Federation president suspended; Wegovy to launch in more countries; and more
Alex Rives, the research lead of Meta’s former AI protein team, is interim CEO for new startup EvolutionaryScale, which is developing biological large language models.
ormer Meta researchers who developed an AI language model for biology have launched a new startup and raised at least $40 million, Forbes has learned.…
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Rating) have been given a consensus rating of “Hold” by the twenty-three research firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation and five have issued a buy recommendation on the […]
Fate Therapeutics (NASDAQ:FATE – Get Rating) had its target price lowered by Stifel Nicolaus from $5.30 to $5.00 in a research report sent to investors on Thursday, The Fly reports. Several other analysts also recently weighed in on the stock. HC Wainwright downgraded shares of Fate Therapeutics from a buy rating to a neutral rating […]